CompaniesAlpharma

Alpharma

defunct

About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (4)

Total Trials

4

As Lead Sponsor

0

As Collaborator

4

Total Enrollment

64

By Phase

PHASE3: 1

By Status

COMPLETED: 3UNKNOWN: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2005

2006

2007

2008

2009

2010

2011

2012

Today

Hover over trial bars to see details

Recent Trials

NCT00261326Collaborator

Simvastatin Treatment of Patients With Acute Optic Neuritis

64 participants

Started: Sep 30, 2006 · Completed: May 31, 2011

NCT00671242Collaborator

Angiogenesis With Positron Emission Tomography (PET) Tracer Uptake

NCT00698373Collaborator

Evaluation of Thoracic Tumors With 18F-FMT and 18F-FDG PET-CT A Clinicopathological Study

NCT00826033Collaborator

Fluorine-18-α-Methyltyrosine Positron Emission Tomography (18F-FMT PET) for Therapy Response in Lung Cancer